Complementary in vitro studies demonstrate that omeprazole-induced AHR activation suppresses ROS production and monocyte chemotactic protein-1 (MCP-1) expression, mitigating hyperoxia-induced injury in human lung adenocarcinoma (H441) cells (27). This evidence concerns the gene CCL2 and lung adenocarcinoma.